CORRECTION FROM SOURCE: Entheon Biomedical Corp. Issues Correction to News Release Dated June 9, 2026

Vancouver, British Columbia–(Newsfile Corp. – June 9, 2026) – Entheon Biomedical Corp. (CSE: ENBI.X) (OTCID: ENTBF) (FSE: 1XU) (“Entheon” or the “Company“) wishes to correct the effective date of the appointment of Adam Emes as a director of the Company as stated in the Company’s news release dated June 9, 2026. The appointment of Mr. Emes to the Company’s Board of Directors is effective June 9, 2026, not April 3, 2025 as previously stated. All other information contained in the news release dated June 9, 2026 remains unchanged.

About Entheon Biomedical Corp.
Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders.

On Behalf of the Board of Directors,
Timothy Ko, CEO and Director

For more information, please contact the Company at:
Entheon Biomedical Corp.
Timothy Ko, CEO
1 (604) 562-3932
[email protected]
https://entheonbiomedical.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300836

मित्रों,
मातृभूमि समाचार का उद्देश्य मीडिया जगत का ऐसा उपकरण बनाना है, जिसके माध्यम से हम व्यवसायिक मीडिया जगत और पत्रकारिता के सिद्धांतों में समन्वय स्थापित कर सकें। इस उद्देश्य की पूर्ति के लिए हमें आपका सहयोग चाहिए है। कृपया इस हेतु हमें दान देकर सहयोग प्रदान करने की कृपा करें। हमें दान करने के लिए निम्न लिंक पर क्लिक करें -- Click Here

* 1 माह के लिए Rs 1000.00 / 1 वर्ष के लिए Rs 10,000.00

Contact us

About Saransh Kanaujia

Saransh Kanaujia is currently editor of Matribhumi Samachar Group. He earlier worked with Hindusthan Samachar News Agency. He is also associated with many organizations.

Check Also

Shri Physio Launches Father’s Day Special Sound Healing Experience

A Gift of Peace for the Man Who Gives Everything Chennai, June 2026: Marking Father’s …